Chester County News and Community Website
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network’s Oncology Research Program has awarded funding for several research initiatives focused on improving treatment and quality of life for patients with …
NCCN Awards Funding for Chronic Myeloid Leukemia Research Projects Read More
MALVERN, PA — An evening of hope, community, and cutting-edge science is coming together in Malvern as Pennies in Action prepares to host its annual Showers of Hope Gala.
Malvern’s Pennies in Action Gala Supports Breakthrough Cancer Research Read More
KING OF PRUSSIA, PA — SEED Therapeutics, Inc. said it will present research on an RBM39 degrader targeting neuroblastoma at the 2026 American Association for Cancer Research annual meeting in …
SEED Therapeutics to Present Neuroblastoma Data at AACR Meeting Read More
CHESTERBROOK, PA — Persevere Therapeutics, Inc., a clinical-stage oncology biotechnology company, announced its launch following a period of stealth operations and the initial close of a seed financing round.
Persevere Therapeutics Launches With Cancer Drug Program and Seed Funding Read More
PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) reported topline results from a Phase 2 clinical trial evaluating a dissolvable microneedle patch designed to deliver chemotherapy directly into basal cell …
Medicus Pharma Reports Phase 2 Results for Skin Cancer Patch Read More PLYMOUTH MEETING, PA — A study published in the February 2026 issue of JNCCN—Journal of the National Comprehensive Cancer Network found that incorporating prostate-specific membrane antigen PET/CT scans into evaluation …
Study Finds PSMA PET/CT Scans May Guide Treatment After Prostate Cancer Recurrence Read More
What This Means for You Firefighters: More than 40,000 firefighters have enrolled in a national cancer registry studying job-related cancer risks; enrollment remains open nationwide. Consumers: Certain lots of Rosabella …
CDC Expands Firefighter Cancer Registry as Drug-Resistant Salmonella Outbreak Prompts Supplement Recall Read More
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) announced the publication of two abstracts featuring preclinical data from its JAK2V617F mutant-selective inhibitor program and CALR-targeted degrader antibody conjugates (DACs) discovery …
Prelude Therapeutics Highlights Groundbreaking Blood Cancer Research at ASH 2025 Read More PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has announced new funding to support quality improvement projects aimed at advancing breast cancer outcomes. The …
NCCN Oncology Research Program Announces New Funding for Breast Cancer Quality Initiatives Read More
AUDUBON, PA — CertaPro Painters® has launched its seventh annual Paint it Pink campaign in partnership with the Breast Cancer Research Foundation (BCRF) and Breast Cancer Canada, continuing its mission …
CertaPro Painters Launches Seventh Annual ‘Paint It Pink’ Campaign for Breast Cancer Research Read More